Biomedical Engineering Reference
In-Depth Information
TABLE 1.1 Medical Applications of some NMs—Cont'd
NMs
Medical applications
References
Tran et al.,
215
Bakry et al.
216
Carbon
nanotubes
Tissue regeneration
Carbon
nanotubes
Biosensors
Wang et al.
217
Polymers
Gene delivery
Dang and Leong,
218
Govender
et al.
211
Polymers
Drug delivery
Ge et al.,
219
Gelperina et al.,
220
Lindhart,
221
Kreuter
222
Armentano et al.,
223
Koegler and
Griffith224
224
Polymers and
nanocomposites
Tissue engineering
In January 2012, Cientifica
225
tracked the growth of government funding to a
total of $67.5 billion from 2000 to 2011. They have indicated that nano-enabled
drug delivery therapeutics will grow from a current value of $2.3 billion to $136
billion by the year 2021 and will represent approximately 15% of the global
nanotechnology market in 2021. It is the healthcare sector that offers the great-
est opportunity to add value to NMs with China as the fastest-growing market
sector
225
. The CEO of Cientifica, Tim Harper, stated that drug delivery with
NMs offers higher margins than other uses of NMs and allows manufacturers
to harness more value than supplying materials for paint or sunscreen
225
. The
drug and pharmaceutical industry benefits from the formulation of nano-enabled
drugs because this enables the extension of patents maintaining if not increasing
their existing revenue sources. By 2021, the global growth in the drug delivery
market will be led by Asia with a CAGR of 32.5%. The largest Asian market
for nano-based drug delivery systems will be China that will have a worth more
than $18 billion and representing 43% of the Asian market.
225
In other countries,
France is forecast to surpass Japan as a drug delivery market within 10 years.
BCC research, on the other hand, reported that the global nanomedicine
market reached $63.8 billion in 2010 and $72.8 billion in 2011.
226
They pre-
dicted that the market is expected to grow to $130.9 billion by 2016 at a CAGR
of 12.5% in 2011-2016.
226
They reported that the central nervous system (CNS)
products market reached $11.7 billion in 2010 and $14.0 billion in 2011 and
expect this market to grow to $29.5 billion by 2016 with a CAGR of 16.1% in
2011-2016 while the anticancer products market reached $25.2 billion in 2010
and $28.0 billion in 2011
226
. It is expected to reach $46.7 billion by 2016 at a
CAGR of 10.8% in 2011-2016, they said in the report (
Figure 1.2
).
Chapter 2 of this topic provides an overview of the various NMs that are
currently very useful in nanomedicine. A few of the sNMs were provided with
